Maternal stress and depression alter infant DNA, with potential lifelong impact

Maternal stress and depression during pregnancy and postpartum are linked to DNA methylation changes in infants, potentially affecting their development and long-term health.

Dr. Fatima Cody Stanford, Associate Professor of Medicine and Pediatrics at Harvard Medical School, Joins Clearmind Medicine’s Scientific Advisory Board – Psychedelic Alpha

Tel Aviv, Israel/Vancouver, Canada, July 11, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the “Company”), a biotech company

July 12, 2023

Cabozantinib Plus Atezolizumab Improves PFS in Metastatic CRPC

In patients with metastatic castration-resistant prostate cancer (mCRPC) whose disease progressed on a novel hormonal therapy, the combination of cabozantinib (Cabometyx) plus atezolizumab (Tecentriq) improved

February 23, 2024

MindBio Announces Proposed Issuance of Listed Securities | Psychedelic Invest

Vancouver, British Columbia –TheNewswire –October 16, 2024–MindBio Therapeutics Corp. (CSE: MBIO); (Frankfurt: WF6),(the “Company” or “MindBio”),a leading biopharmaceutical company in psychiatric medicine development, is pleased to provide

October 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.